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Background: Adhering to the Mediterranean diet (MeDi) is known to be beneficial with
regard to many age-associated diseases including cardiovascular diseases and type 2
diabetes. Recent studies also suggest an impact on cognition and brain structure, and
increasing effort is made to track effects down to single nutrients.
Aims: We aimed to review whether two MeDi components, i.e., long-chain omega-3
fatty acids (LC-n3-FA) derived from sea-fish, and plant polyphenols including resveratrol
(RSV), exert positive effects on brain health in aging.
Content: We summarized health benefits associated with the MeDi and evaluated
available studies on the effect of (1) fish-consumption and LC-n3-FA supplementation
as well as (2) diet-derived or supplementary polyphenols such as RSV, on cognitive
performance and brain structure in animal models and human studies. Also, we
discussed possible underlying mechanisms.
Conclusion: A majority of available studies suggest that consumption of LC-n3-FA
with fish or fishoil-supplements exerts positive effects on brain health and cognition in
older humans. However, more large-scale randomized controlled trials are needed to
draw definite recommendations. Considering polyphenols and RSV, only few controlled
studies are available to date, yet the evidence based on animal research and first
interventional human trials is promising and warrants further investigation. In addition,
the concept of food synergy within the MeDi encourages future trials that evaluate the
impact of comprehensive lifestyle patterns to help maintaining cognitive functions into
old age.
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Background: Health Benefits of the Mediterranean Diet
According to the ‘‘Global Strategy on Diet, Physical Activity and Health’’, a review developed by
the World Health Organization (WHO), the Mediterranean Diet (MeDi) is a promising strategy
to prevent from diseases and enhance quality of life (World Health Organization, 2009). The
review aims specifically on interventions, that reduce the risk for non-communicable diseases like
cerebro- and cardiovascular diseases, cancer, respiratory diseases, diabetes and neurodegenerative
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diseases, which comprise the leading causes of death worldwide
(World Health Organization, 2009). The MeDi was first
investigated by Ancel Keys in the 1950s during his Seven
Countries Study, a large-scale prospective cohort-study with
more than 11,000 participants (Keys, 1970; Keys et al., 1986).
Keys et al. (1986) observed a considerable difference in the eating
pattern of Southern European countries, compared to Northern
Europe and the USA. This Mediterranean eating pattern and
related low intake percentage of total energy from saturated
fatty acids correlated with lower serum cholesterol and lower
blood pressure in Mediterranean countries, which were again
associated with a lower coronary mortality and a lower risk
for the above mentioned diseases in comparison to countries
adhering to a Western-type diet (Keys et al., 1986).
Distinctive for the MeDi is the high consumption of fruits,
vegetables, grains as well as sea-fish on regular basis, while the
intake of meat and dairy products, just as sweets and convenience
food is rather low (Trichopoulou et al., 1995; Gotsis et al.,
2015). In addition, the regular consumption of red wine (mainly
served with food) and olive oil (as principal source of fat) is
characteristic for the MeDi (Willett et al., 1995). For a detailed
description of the MeDi, often displayed as food pyramid, see
Bach-Faig et al. (2011).
Over the last decades, epidemiologic studies supported and
extended Keys’ findings to a multitude of health benefits that
are provided by the MeDi, e.g., with regard to cancer and
cardiovascular diseases (Couto et al., 2011; Lopez-Garcia et al.,
2014; Gotsis et al., 2015). More recently, research also focused on
neurodegenerative diseases and the impact ofMeDi on cognition.
For reviews, see e.g., Lourida et al. (2013) and van de Rest
et al. (2015). For example, Scarmeas et al. (2006) observed in
a prospective cohort of 2258 community-based non-demented
individuals that higher adherence to theMeDi is associated with a
significant reduction in the risk for Alzheimer’s disease (AD). In
a systematic review, Lourida et al. (2013) described a reasonably
consistent pattern of associations between adherence to theMeDi
and related lower risks for AD, reduced rates of cognitive decline
as well as better cognitive function. Most recently, Valls-Pedret
et al. (2015) described positive results of a long-term randomized
clinical trial (RCT) in 334 participants with high cardiovascular
risk at a mean age of 67 years (PREDIMED study), providing an
even stronger level of scientific evidence than results based on
observational studies (Valls-Pedret and Ros, 2013): Here, a MeDi
supplemented with either olive oil or nuts, in comparison to a
control diet, was associated with improved cognitive functions at
4-year follow-up (Valls-Pedret et al., 2015).
These beneficial effects might be due to multiple biological
mechanisms, such as lower concentrations of serum-cholesterol
in Mediterranean areas and a related decrease of cardiovascular
risk, which were among the first findings by Keys et al.
(1986). More specifically, adherence to the MeDi is associated
with a reduced risk for coronary heart diseases and metabolic
syndrome including hypertension and dyslipidemia, which have
been associated with the development of cognitive impairments
(for review see e.g., van den Berg et al., 2009; Yates et al.,
2012). Additionally, adhering to the MeDi might prevent from
disturbances in insulin/glucosemetabolism that can result in type
2-diabetesmellitus (DM-2), which is associated with an increased
risk for AD and cognitive impairments (Biessels et al., 2006; Hu
et al., 2013). Even in the absence of manifest DM-2, chronically
elevated levels of blood-glucose have shown to exert negative
effects on AD risk and memory performance in older adults
(Crane et al., 2013; Kerti et al., 2013).
In sum, the MeDi has been shown to exert positive effects
on risk for AD and cognitive functions during aging, which is
probably mediated through reductions in vascular risk factors
and benefits on lipid and glucose metabolism. Moreover, based
on animal research it has been postulated that specific nutrients
could exert even more directly protective effects on the aging
brain, e.g., considering amyloid-beta metabolism (Allès et al.,
2012). As the MeDi is a complex eating pattern, though, a
multitude of single components could cause beneficial effects
(Jacobs et al., 2009; Gotsis et al., 2015). Understanding these
underlying mechanisms and eventually develop preventive and
therapeutic strategies based on those insights, are important
issues for future research.
This review aims to evaluate recent findings concerning the
effects of single components of the MeDi and their impact on
cognition. Firstly, we focus on long chain omega-3 fatty acids
(LC-n3-FA) derived from fish, as they distinguish theMeDi from
other diets and are consumed with high frequency (Tangney
et al., 2014). Secondly, our focus is on plant polyphenols
(including resveratrol), which occur mainly in fruit, tea and
red wine (Manach et al., 2004). The deliberate consumption of
red wine is a well-known feature of the MeDi and especially
resveratrol is assigned beneficial effects with regard to overall
health, as well as cognition (Baur and Sinclair, 2006; Witte et al.,
2014). Both nutrients attracted increasing research interest in the
last years.
Impact of Omega-3 Fatty Acids on the
Brain
One characteristic of the MeDi is a high intake of unsaturated
fatty acids, including the long-chain omega-3 polyunsaturated
fatty acids (LC-n3-FA) eicosapentaenoic acid (EPA, C20:5, n-3)
and docosahexaenoic acid (DHA, C22:6, n-3; Figure 1). The
main source of DHA and EPA in the human diet is fatty sea
fish like mackerels or salmon (Max Rubner-Institut, 2011). DHA
and EPA cannot be efficiently synthesized by human enzymes
and are therefore regarded as semi-essential (Burdge and Calder,
2005; Burdge, 2006; Sala-Vila and Ros, 2011). Astrocytes in the
brain are a major site for the processing of LC-n3-FA. They
elongate and desaturate precursor fatty acids such as linoleic
acid and the vegetable LC-n3-FA alpha-linolenic acid (ALA) to
form EPA and DHA (Moore et al., 1991). Notably, not only the
absolute amount of DHA and EPA might be important, but also
the ratio of the precursors, as with different precursor ratios,
different conversion rates to DHA and EPA occur (Kaur et al.,
2014). In addition, intake of ALA, contained e.g., in nuts, might
also directly contribute to the beneficial effects of the MeDi on
cognition (Blondeau et al., 2009; Valls-Pedret et al., 2015; for a
detailed discussion of possibly distinct effects of ALA, EPA and
DHA please see Freemantle et al., 2006).
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FIGURE 1 | Postulated effects of long-chain Omega-3 Fatty Acids (Eicosapentaenoic Acid, EPA and Docosahexaenoic Acid, DHA) with regard to
brain health and their main dietary sources.
It is widely accepted, that LC-n3-FA are crucial for the
growth and development of the infant brain during pregnancy
and after birth (Kris-Etherton et al., 2009). The predominant
LC-n3-FA DHA alone comprises 10–20% of total fatty acids
of the brain and is thought to be important with regard to
neuronal differentiation, synaptogenesis, and synaptic function
(McNamara and Carlson, 2006). It has also been proposed that
the access to DHA during hominid evolution played a key role
in increasing the brain to body-mass ratio (Crawford et al., 1999,
2013). However, due to the easy availability of processed food in
Western societies today, the consumption of saturated fatty acids
and trans-fatty acids increased, while that of DHA decreased.
This has been speculated to contribute to an increased incidence
of brain disorders such as major depression (Su et al., 2003).
Considering the abundance of DHA in brain tissue and its
importance for brain development and evolution, it is reasonable
to suppose that DHA also contributes to the evolvement
and maintenance of proper cognitive functioning in later life
(Gómez-Pinilla, 2008). Indeed, several experimental animal
studies demonstrated superior learning and better memory
performance in rodents that received supplementary DHA with
their diet (Morris et al., 2005). DHA might have a beneficial
impact even during pathological conditions like AD. Lim et al.
(2005) found in aged mice on a DHA-enriched diet a significant
reduction of total amyloid β (A-β) by more than 70% when
compared with low-DHA or control chow diets. This could
be neuroprotective, given the probable downstream toxicity
of A-β deposition and its implications in the development
of AD (Lim et al., 2005). That is a further finding on the
protective properties of DHA against synaptic loss, which is
a critical issue in concerns of AD and seems to support the
hypothesis that DHA is protective against AD (Calon et al.,
2004).
These findings are in line with human epidemiological studies
that report associations between the consumption of fish in
general (Barberger-Gateau et al., 2005; Morris et al., 2005), as
well as LC-n3-FA e.g., as dietary fishoil supplement (McCann
and Ames, 2005; Gómez-Pinilla, 2008), with better cognitive
performances and lower risk of dementia (for a review, see
Fotuhi et al., 2009). For example, a large-scale prospective cohort
study with 6158 residents of a community in Chicago of 65
years and older, estimated that fish consumption was associated
with slower cognitive decline with age, assessed using a global
cognitive score (Morris et al., 2005).
The evidence for positive effects of LC-n3-FA fishoil
supplementation on cognitive functions in normal and
pathological aging based on placebo-controlled RCTs is less
clear, see Table 1 for an overview. In an early double-blind
RCT in 204 AD patients, Freund-Levi et al. (2006) observed
positive effects of LC-n3-FA in a small group of those with
very mild AD who took supplementary LC-n3-FA over
6 months. These findings are in line with a 24-week RCT by
Chiu et al. (2008) in 46 participants. Here the authors also
concluded that LC-n3-FA improved general clinical function in
patients with mild or moderate AD, as well as mild cognitive
impairment (Chiu et al., 2008). In an own double-blind
prospective interventional study, it was shown that LC-n3-FA
improved executive functions and gray matter volume, as well
as white matter microstructure in healthy older individuals,
after 26 weeks of fish oil supplementation (Witte et al., 2013).
Yurko-Mauro et al. (2010) observed in another RCT with
485 healthy subjects older than 55 years that 24 weeks of
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TABLE 1 | Characteristics of studies reporting associations between fish-consumption or LC-n3-FA-supplementation and cognition.
Author (year) Participants Duration Intervention Measured outcome Results
sample size/age (years)
Chiu et al.
(2008)
N = 46
memory
complaints
I: 74.0
(70.1–77.8)
P: 76.5
(71.8–81.1)
24 weeks 1.8 g
Omega-3
PUFAs/d
Placebo ADAS-cog AD group: ◦ MCI
group: +
Dangour et al.
(2010)
N = 867
healthy
I: 74.7 ± 2.5
P: 74.6 ± 2.7
24 months 200 mg EPA +
500 mg DHA/d
Placebo Extensive NP test battery Whole group: ◦
Freund-Levi et al.
(2006)
N = 204
AD
I: 72.6 ± 9.0
P: 72.9 ± 8.6
6 months 1.7 g DHA/d
and 0.6 g EPA/d
Placebo ADAS-cog MMSE Whole group: ◦ Sub-
group: +
Morris et al.
(2005)
N = 6185
healthy
I1: 74.6
I2: 74.2
I3: 73.9
6 years Observational Global cognitive score Whole group: +
Quinn et al.
(2010)
N = 402
mild to
moderate
AD
I: 76 ± 9.3
P: 76 ± 7.8
18 months 2 g/d DHA Placebo ADAS-cog Clinical Dementia
Rating (CDR)
sum of boxes
Whole group: ◦
Reddy et al.
(2011)
N = 27
schizophrenia
18–45 24 weeks 2 g/d EPA Wisconsin Card Sort Test Whole group: +
Tan et al.
(2012)
N = 1575
healthy
67 ± 9 – Observational (Red blood cell Extensive NP test battery Whole group: +
EPA + DHA)
van de Rest et al.
(2008)
N = 302
healthy
I1800:
69.9 ± 3.4
I400: 69.5 ± 3.2
P: 70.1 ± 3.7
26 weeks 1800 mg/d
EPA-DHA
400 mg/d
EPA-DHA
Placebo Extensive NP test battery Whole group: ◦
Witte et al.
(2013)
N = 65
healthy
I: 65 ± 6.3
P: 62.9 ± 6.8
26 weeks 2.2 g/d
EPA-DHA
Placebo Extensive NP test battery Whole group: +
Yurko-Mauro
et al. (2010)
N = 485
healthy
I: 70 ± 9.3
P: 70 ± 8.7
24 weeks 900 mg DHA/d CANTAB Paired Associate Learning Whole group: +
AD, Alzheimer’s Disease; ADAS-cog, Alzheimer’s Disease Assessment Scale, cognitive subscale; DHA, docosahexaenoic acid; EPA, eicosapentaenoic acid; I, age of
intervention group; MCI, Mild Cognitive Impairment; MMSE, Mini-Mental State Examination; NP, neuropsychological; P, age of placebo group; +, positive effect on
cognition; ◦, no effect on cognition.
supplementation with 900 mg/d DHA improved learning and
memory function.
Supporting these findings, Pottala et al. (2014) observed in a
cross-sectional analysis, that a higher LC-n3-FA intake (indicated
by higher proportions of DHA and EPA in the membranes
of blood erythrocytes, see Harris and Von Schacky, 2004) was
correlated to higher total brain and hippocampal volume in
1111 postmenopausal women. In another cross-sectional study
by Tan et al. (2012) in 1575 elderly participants, those with
lower DHA had also lower scores on tests of executive function
and abstract thinking. Similarly, executive functions could be
improved after 24 weeks of supplementary LC-n3-FA intake
(2 g EPA/d) in 27 schizophrenic patients in an open-label study
(Reddy et al., 2011).
In contrast, other interventional studies in AD patients
(Quinn et al., 2010) or healthy older adults (van de Rest
et al., 2008; Dangour et al., 2010) did not support the
positive effects of fish oil consumption. These inconsistent
results might be explained due to differences in dosage
and duration between studies, e.g., that LC-n3-FA intake
might not have been sufficient to exert statistically significant
effects on cognition. Furthermore studies might differ in
intake instructions and cohort characteristics. It has also
been noted that not only the amount of LC-n3-FA, but
also the overall dietary fat-composition is considerably critical
for brain functions (Morris et al., 2005). For example, an
unfavorable fat composition might affect cognitive aging more
than total fat intake itself (Okereke et al., 2012). Especially
saturated fatty acids and trans-fatty acids are supposed to
increase the risk of AD (Hooijmans et al., 2007; Studzinski
et al., 2009; Ramassamy and Belkace´mi, 2011) and affect
cognition (Greenwood and Winocur, 2005), which could be
due to decreased Brain-derived neurotrophic factor (BDNF)
related synaptic plasticity (Molteni et al., 2002). Thus, it
might be speculated that the positive effects of supplementary
LC-n3-FA could be masked out by the negative effects
of concurrent high saturated- and trans- fatty acid intake.
According to the latest Cochrane reviews, it is not yet clear
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that dietary or supplemental LC-n3-FA alter total mortality,
combined cardiovascular events or cancers in people with,
or at high risk of, cardiovascular disease or in the general
population (Hooper et al., 2004). The same stated Sydenham
et al. (2012) for LC-n3-FA and dementia. They could not
state benefits for cognitive health for older people taking
omega-3 supplements. However, none of the mentioned
studies reported severe adverse effects of fish or fish oil
consumption.
Underlying mechanisms of positive effects of LC-n3-FA
on cognition could include a reduction of cardiovascular risk
factors, e.g., by improving cerebral blood flow and lowering
triacylglycerol levels as found in non-human primates and rats
(Katayama et al., 1997; Tsukada et al., 2000; Fotuhi et al.,
2009). More direct neuronal effects of LC-n3-FA are e.g.,
stimulation of neurogenesis and neurite outgrowth (Kawakita
et al., 2006) and enhancement of synaptic membrane fluidity
(Cansev and Wurtman, 2007). Also, LC-n3-FA have been
found to increase the expression of myelin-related proteins
(Salvati et al., 2008), which could contribute to improved
axonal transmission and thus better neuronal signaling. In
addition, LC-n3-FA are thought to upregulate several genes
such as Sir2, involved in maintaining synaptic function and
plasticity (Wu et al., 2007). A recent study in mice showed an
increase of neuroprotectin D-1 (NPD-1) after fish oil treatment
(Afshordel et al., 2015). NPD-1 represents a neuroprotective
compound that is derived from unesterified DHA (Afshordel
et al., 2015).
Moreover, LC-n3-FA play several roles with regard to
inflammatory processes. DHA and EPA are capable of competing
with arachidonic acid in the production of eicosanoids,
which results in the production of biologically less active
thromboxans and therefore in a better hemodynamic, vascular
tone and inflammation (Mori and Beilin, 2004). LC-n3-FA
might also upregulate the expression of antioxidant enzymes
and downregulate genes associated with production of reactive
oxygen species (ROS), such as peroxisome proliferator-activated
receptors gamma (PPAR-γ; Takahashi et al., 2002; Mori and
Beilin, 2004). Additionally, DHA has been implicated in reducing
inflammation through fatty acid derivatives such as NPD-1 (Cole
et al., 2010) and resolvin species (Kohli and Levy, 2009).
In sum, promising evidence indicates that LC-n3-FA,
especially DHA, exert positive effects on brain structure and
cognitive functions. Yet, more large-scale RCTs are needed
before fish oil intake could be fully recommended as preventive
strategy against cognitive decline in the older population.
Polyphenols and their Impact on the Brain
A further class of substances that is supposed to contribute to
the beneficial effects of the Mediterranean Diet (MeDi) is that of
polyphenols (Figure 2). Polyphenols are secondary metabolites
of plants and characterized by the chemical structure of hydroxyl
groups on aromatic rings (Manach et al., 2004). They are quite
abundant in our diet and several thousand molecules have
been identified to have polyphenol character (Manach et al.,
2004). One polyphenol agent that came into research focus
is resveratrol (RSV). It occurs naturally in the skin of red
grapes, red wine, blueberries, peanuts and Japanese knotweed
(Baur and Sinclair, 2006; Baur et al., 2006; Ingram et al., 2006).
Another group, the flavonols, are part of the flavonoid family
that is found in various fruits, cocoa, beans and the Ginkgo
biloba tree (Gómez-Pinilla, 2008). Flavonols contain anti-
inflammatory properties among several other complex actions
(for review, see Gómez-Pinilla, 2008). Although polyphenols are
somewhat heterogeneous regarding their chemical properties,
they seem to have some effects in common with regard
to cardiovascular health and (at least for some polyphenols)
antioxidant capacity (Halliwell, 2007; Habauzit and Morand,
2012).
FIGURE 2 | Postulated effects of Polyphenols including Resveratrol with regard to brain health and their main dietary sources.
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In vitro, several polyphenols including RSV eliminate a
multitude of ROS, including hydroxyl radicals, peroxyl radicals
hypochlorous acid and in part superoxide radical (Halliwell,
2007). ROS are considered to be toxic and ROS-induced cell
damage is assumed to contribute to the process of aging
(Liochev, 2013). In rats, polyphenols have been shown to increase
heat-shock protein (HSP) 70 and insulin-like growth factor 1
(IGF-1) expression in the hippocampus, which protects against
kainate-induced cell damage and benefits learning and memory
performance (Casadesus et al., 2004; Galli et al., 2006). Reduced
hippocampal neurodegeneration has also been shown after RSV
administration in rodent models for AD/tauopathies (Kim et al.,
2007). In addition, administration of RSV-containing red wine
was found to preserve spatial memory, while reducing Aβ
neuropathology (Wang et al., 2010). In a non-human primate
study, supplementary RSV for 18 months increased spatial
memory performance compared to placebo (Dal-Pan et al.,
2011).
Considering human studies, there is a considerable
heterogeneity in study quality, design and polyphenol
formula/dosage (Crichton et al., 2013). See Table 2 for an
overview. In a cross-sectional study by Nurk et al. (2009) with
2,031 participants aged 70–74 years from the Hordaland Health
Study in Norway, a diet over 1 year high in some flavonol-rich
foods, such as chocolate, wine and tea, was associated with better
performance in several cognitive abilities in a dose-dependent
manner in comparison to a non-consumer group. Only a few
placebo-controlled interventional studies are available to date,
such as Kennedy et al. (2010). This study assessed the effects of
250 and 500 mg oral RSV on cognitive performance in a RCT
crossover study in 22 healthy adults, with the result that even
single doses of orally administered RSV can modulate cerebral
blood flow variables, measured usingMRI (Kennedy et al., 2010).
In another study, blueberry supplementation (wild blueberry
juice) improved paired associate learning and word list recall, as
well as paired associate learning in a small sample of nine older
adults after comparison with a matched, placebo-controlled
sample (Krikorian et al., 2010). In a double-blind, clinical trial
by Small et al. (2014) intake of a pill-based nutraceutical that
contained a proprietary formulation of blueberry (including
RSV), green tea, carnosine, vitamin D3 and biovin, resulted
in significantly increased processing speed of 52 participants
compared to placebo (N = 53). In an own study with 46 healthy
overweight older individuals, a daily intake of 200 mg RSV (in
a formula with quercetin) over 26 weeks compared to placebo
intake significantly improved memory performance (Witte
et al., 2014). In addition, glycated hemoglobin (HbA1c) in
peripheral blood was significantly reduced after RSV treatment,
and this reduction in HbA1c correlated with higher functional
connectivity of the hippocampus, measured using resting-
state functional MRI in the same subjects. Notably, changes
in functional connectivity were found to correlate with the
observed increases in memory, pointing to ameliorated glucose
metabolism as one underlying mechanism of the positive effects
of RSV on cognition (Witte et al., 2014). Also, Brickman et al.
(2014) reported recently in a randomized study on flavonols
with 37 healthy 50 69 year old subjects using functional MRI that
a diet high in cocoa-flavanol over 3 months enhanced memory
function and improved related activation in the dentate gyrus,
the hippocampus region characterized by life-long neurogenesis,
in comparison to a diet low in cocoa-flavanol.
Both RSV and flavonols could contribute to a better
cognitive performance due to their protective effects against
oxidative stress, which increases with age and is a risk
factor for age-associated cognitive decline. Further possible
neuroprotective mechanisms of polyphenols including RSV are
reduced mitochondrial dysfunction, glucose toxicity, oxidative
damage, and chronic inflammation, by improving glucose
metabolism and vascular functions and by activating so-called
longevity genes including the sirtuins. For further discussions see
TABLE 2 | Characteristics of studies reporting associations between flavonol or RSV consumption and cognition.
Author (year) Participants Duration Intervention Measured outcome Results
(Polyphenol)sample size/age
Kennedy et al. (2010) N = 22 Healthy 20.17 y Single dose 250 mg (RSV) 500 mg (RSV) Placebo Cognitive
task
Cerebral blood flow +
Krikorian et al. (2010) N= 9,
placebo
N = 7
Healthy
76.2 ± 5.2 y
12 weeks Daily consumption of wild blueberry juice Paired
associate
learning
Word list recall +
Nurk et al. (2009) N = 2031 Healthy 70–74 y Cross-
sectional
Observational (Chocolate, Wine, Tea) Extensive NP test battery +
Small et al. (2014) N = 52,
placebo
N = 53
Healthy
I: 72.82
P: 74.34
2 months Pill-based nutraceutical Placebo Extensive NP test battery +
Witte et al. (2014) N = 23,
Placebo
N = 23
Healthy,
overweight
I: 64.8 ± 6.8
P: 63.7 ± 5.3
26 weeks 200 mg/d RSV Placebo Auditory Verbal Learning Test +
Brickman et al. (2014) N = 37 Healthy 50–69 y 3 months High cocoa flavonol-diet Low
flavonol-
diet
ModBent task +
NP, Neuropsychological; P, Age of placebo group; RSV, resveratrol; I, Age of intervention group; y, years of age; +, positive effect on cognition; ◦, no effect on cognition.
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e.g., Calabrese et al. (2008, 2009), Sun et al. (2011), Crichton et al.
(2013) and Witte et al. (2014).
Conclusion and Outlook
A majority of available studies on the topic suggest that
consumption of LC-n3-FA with fish or fish oil-supplements and
plant polyphenols such as flavonols and RSV exerts positive
effects on brain health and cognition in older humans. However,
with regard to LC-n3-FA supplementation using fish oil, a
final recommendation based on RCTs cannot be drawn, as
some studies could not detect a positive effect. Here, more
large-scale RCTs that, for example, also control for other
fatty acid intake are needed to support a significant benefit
of regular supplementary LC-n3-FA intake in maintaining
cognitive performance. Considering polyphenols, the evidence
based on high-quality RCTs is even less clear, given that only
few reliable studies are available to date with different formulas
and different duration of the intervention. Yet, those few studies
were promising, and the animal literature provided convincing
examples that polyphenols are highly potent in activating
possible neuroprotective pathways, warranting the initiation
of large-scale RCTs in humans on supplementary flavonol or
RSV. Moreover, attempts to study in parallel the underlying
mechanisms in humans, e.g., using high-resolution MRI, are
especially important to further strengthen possible hypotheses
that are mainly based on animal research. Future studies also
need to address whether intervention-induced changes in LC-
n3-FA or polyphenol intake relate to changes in fatty acid or
polyphenol content at the brain level in humans, e.g., using post-
mortem techniques.
Besides that, additive or synergistic effects between single
dietary components come increasingly into focus. Diet is more
than the sum of its components, which is considered in the
concept of ‘‘food synergy’’. The assumption is that interactions
and synergistic effects of the single food components occur as
they are consumed in the framework of a balanced diet (Jacobs
et al., 2009). For example, antioxidant nutrients can protect
LC-n3-FA from peroxidation to which they are particularly
susceptible due to their multiple double bounds (Barberger-
Gateau, 2014). Also, even though studies on single nutrients
and their interactions might help to explain the beneficial
effects of dietary patterns, there is an even greater framework.
Yannakoulia et al. (2015) propose not only the additive and
synergistic effects of single nutrients or foods, but also add
other lifestyle behaviors like physical activity, social support,
sharing food, having lengthy meals and post-lunch siestas to
that explanatory approach. Regardless of all the modernization
processes happening (Bach-Faig et al., 2011), the lifestyle of the
Mediterranean countries remains an UNESCO World Cultural
Heritage and could thus contribute to a multitude of insights
regarding brain functioning and healthy aging (Bach-Faig et al.,
2011). First publications of large-scale RCTs, such as Valls-
Pedret et al. (2015) and Ngandu et al. (2015), provide a strong
level of scientific evidence for the beneficial effects of the
MeDi on cognitive functions. In addition, ongoing multidomain
interventional trials like the Finnish Geriatric Intervention Study
to Prevent Cognitive Impairment and Disability (FINGER) will
help to gain further insights into the beneficial effects of the
MeDi-lifestyle and its components on cognition and brain
function. The FINGER-study is a multi-center RCT and includes
nutritional guidance, regular exercise, cognitive training and
social activity, as well as management of metabolic and vascular
risk factors, and might thus shed comprehensively further light
on possible mechanisms of how modifiable lifestyle factors could
help to maintain cognitive functions throughout age (Kivipelto
et al., 2013).
Summing up, LC-n3-FA and polyphenols such as RSV are
highly investigated substances in the framework of the MeDi.
Even though, more studies are needed to clarify the main effects
and their underlying mechanisms, they seem to be promising
with regard to their impact on brain structure and function in
aging.
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